The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.
Medtronic, Abbott, Boston Scientific, Medical Microinstruments (MMI) and other device developers earned honors at the 2026 ...
Medtronic (NYSE:MDT) today announced new real-world data from a post-approval study of its In.Pact AV drug-coated balloon ...
Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...
Medtronic announced today the launch of CareLink Mobile Application, which the company calls the first mobile application that pairs with implantable cardiac devices. The app is available for the ...
Medtronic plc (NYSE:MDT) is one of the undervalued large cap stocks to buy. On April 6, Argus Research analyst David Toung ...
The China Diabetes Devices Market is projected to grow from USD 7.19 billion in 2025 to USD 14.51 billion by 2034, marking a ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of incomplete wall apposition and braid deformation, which could lead to stroke or ...
Medtronic recalled its HeartWare ventricular assist device system because of defects that have been tied to four patient deaths, tctmd reports. 1. The FDA commenced the Class 1 recall May 28 after ...
Cybersecurity vulnerabilities in certain Medtronic CareLink programmers are at the center of the recent voluntary recall. (This story has been updated with an FDA statement.) See Also: A Legal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results